SUPERNUS PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Supernus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
Supernus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $40.8M, a 402% increase year-over-year.
Supernus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $46.1M, a 46.4% decline from 2021.
Supernus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $86M, a 50.5% decline from 2020.
Supernus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was $174M, a 16.9% increase from 2019.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$46.1M	-$39.9M	-46.4%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-09
2021	$86M	-$87.7M	-50.5%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-09
2020	$174M	+$25.1M	+16.9%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-09
2019	$149M	+$4.13M	+2.86%	Jan 1, 2019	Dec 31, 2019	10-K	2022-04-13
2018	$144M	+$44.9M	+45.1%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-08
2017	$99.5M	+$45.3M	+83.6%	Jan 1, 2017	Dec 31, 2017	10-K	2020-02-28
2016	$54.2M	+$33.4M	+160%	Jan 1, 2016	Dec 31, 2016	10-K	2019-03-01
2015	$20.8M	+$26.1M		Jan 1, 2015	Dec 31, 2015	10-K	2018-03-01
2014	-$5.28M	+$56.6M	+91.5%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-16
2013	-$61.9M	-$19.8M	-46.8%	Jan 1, 2013	Dec 31, 2013	10-K/A	2017-01-20
2012	-$42.2M	-$4.42M	-11.7%	Jan 1, 2012	Dec 31, 2012	10-K	2015-03-12
2011	-$37.8M	+$2.37M	+5.91%	Jan 1, 2011	Dec 31, 2011	10-K	2014-03-21
2010	-$40.1M			Jan 1, 2010	Dec 31, 2010	10-K	2013-03-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.